No sections match your search.
Pathophysiology, clinical presentation, MRI diagnosis, outcomes, and management of naturally occurring ischemic stroke in dogs and cats.
Laboratory research using surgically or chemically induced canine models of ischemic stroke (permanent/transient MCA occlusion, embolic and thromboembolic models) for translational study of imaging, neuroprotection, thrombectomy devices, and reperfusion strategies. Not naturally occurring disease.
Intracranial hemorrhage, hypertensive bleeds, vascular malformations, and hemorrhagic transformation in small animals.
Ischemic and hemorrhagic stroke in dogs: pathophysiology, MRI diagnosis, risk factors, clinical registries, and outcomes.
Peripheral and central vestibular disease, differential diagnosis from stroke, and clinical management in dogs and cats.
Seizure disorders as a sequela or mimicker of cerebrovascular events; anti-epileptic management in dogs and cats.
Canine cognitive dysfunction syndrome, vascular contributions to cognitive decline, and neurodegenerative overlap.
Fibrocartilaginous embolism, spinal ischemic myelopathy, and vascular spinal cord disease in dogs.
Hepatic, metabolic, and hypertensive encephalopathy as comorbidities and stroke mimics in small animals.
Inflammatory brain disease, immune-mediated encephalitides, and their overlap with cerebrovascular events in dogs.
Congenital and acquired hydrocephalus, cerebrospinal fluid dynamics, and intracranial pressure management in dogs and cats.
Diagnosis, anatomy, genetics, and clinical assessment of Chiari-like malformation and syringomyelia, predominantly in Cavalier King Charles Spaniels.
Immunosuppressive treatment approaches for dogs with acquired myasthenia gravis.
Molecular diagnostic identification of infectious and vector-borne pathogens causing neurologic disease in dogs and cats.
Blood pressure screening, secondary hypertension, target organ damage, and ACVIM consensus guidelines for dogs and cats.
Cardiogenic embolism, MMVD, dilated cardiomyopathy, and cardiac causes of cerebrovascular events in dogs and cats.
AF-associated stroke risk, anticoagulation strategies, and cardioembolic stroke in dogs and cats.
Arterial and venous thromboembolism, hypercoagulable states, and systemic thromboembolic disease in small animals.
Arterial pathology, vasospasm, and structural vascular abnormalities contributing to cerebrovascular disease.